Centerpoint Advisors’s NuVasive, Inc. NUVA Stock Holding History

Centerpoint Advisors’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-66	Closed	-$3K	–	372
2018 Q2	$3K	Buy	+66	New	+$3.46K	﹤0.01%	274

Other funds holding NUVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Centerpoint Advisors's NUVA Position: Q3 2018 in Review

Centerpoint Advisors sold out of NuVasive, Inc. (NUVA) in Q3 2018, closing a stake of 66 shares — an estimated $3K sold.

Centerpoint Advisors first reported a position in NUVA in Q2 2018 and held it in 1 quarter. The position peaked at $3K in Q2 2018. 287 funds tracked by Wall St. Rank hold NUVA as of Q3 2018.

Centerpoint Advisors reported no remaining NuVasive, Inc. position as of Q3 2018 after selling out during the quarter.
Centerpoint Advisors sold 66 NuVasive, Inc. shares in Q3 2018, an estimated $3K.
Centerpoint Advisors first reported a position in NuVasive, Inc. in Q2 2018 and held it in 1 quarter.
Centerpoint Advisors's NuVasive, Inc. position peaked at $3K in Q2 2018.
287 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2018.

Based on Centerpoint Advisors's 13F filing for Q3 2018, filed 8 Nov 2018.